{
  "resourceType" : "PlanDefinition",
  "id" : "OncologyPlanDefinitionExample",
  "meta" : {
    "profile" : ["https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-oncology-plan-definition"]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Regimen template for AC-T: Doxorubicin + Cyclophosphamide → Paclitaxel, 8 × 21-day cycles</p></div>"
  },
  "extension" : [{
    "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-planned-cycles-extension",
    "valueInteger" : 8
  },
  {
    "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cycle-length-days-extension",
    "valueInteger" : 21
  }],
  "url" : "https://nshr-uat.sha.go.ke/fhir/PlanDefinition/OncologyPlanDefinitionExample",
  "identifier" : [{
    "system" : "https://nshr-uat.sha.go.ke/fhir/regimen-id",
    "value" : "REG-AC-T-V1"
  }],
  "version" : "0.1.0",
  "title" : "AC-T Chemotherapy Regimen (21-day cycles)",
  "type" : {
    "coding" : [{
      "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/plan-definition-type-cs",
      "code" : "REGIMEN-TEMPLATE",
      "display" : "Regimen Template"
    }]
  },
  "status" : "active",
  "date" : "2026-06-08T10:30:33+00:00",
  "publisher" : "Digital Health Agency (DHA), Kenya",
  "contact" : [{
    "name" : "Digital Health Agency (DHA), Kenya",
    "telecom" : [{
      "system" : "url",
      "value" : "https://dha.go.ke"
    },
    {
      "system" : "email",
      "value" : "info@dha.go.ke"
    }]
  },
  {
    "name" : "Digital Health Agency Kenya – FHIR Team",
    "telecom" : [{
      "system" : "email",
      "value" : "info@dha.go.ke",
      "use" : "work"
    },
    {
      "system" : "url",
      "value" : "https://dha.go.ke",
      "use" : "work"
    }]
  }],
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "KE",
      "display" : "Kenya"
    }]
  }],
  "action" : [{
    "title" : "Doxorubicin 60 mg/m² IV — Day 1"
  },
  {
    "title" : "Cyclophosphamide 600 mg/m² IV — Day 1"
  }]
}